Impressive regression of primary liver cancer after treatment with sirolimus

Author： Rizell Magnus   Cahlin Christian   Friman Styrbjörn   Hafström Lo   Lönn Lars   Olausson Michael   Lindner Per  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.44, Iss.5, 2005-07, pp. : 496-496

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regression of liver metastases after treatment with intraperitoneal catumaxomab for malignant ascites due to breast cancer

By Petrelli Fausto   Borgonovo Karen   Lonati Veronica   Elia Stefano   Barni Sandro  

Targeted Oncology, Vol. 8, Iss. 4, 2013-12 ,pp. : 291-294

Springer Publishing Company

Access to resources Recommend Favorite

Follow-up after Primary Treatment for Breast Cancer

By Sakorafas George H.   Tsiotou Adelais G.   Pavlakis George  

Acta Oncologica, Vol. 39, Iss. 8, 2000-11 ,pp. : 935-940

Informa Healthcare

Access to resources Recommend Favorite

Recurrence after Different Primary Treatment for Cancer of the Supraglottic Larynx

By Vermund Halvor   Boysen Morten   Evensen Jan F.   Jacobsen Anne-Birgitte   Natvig Ketil   Tausjo Johan   Wiley Albert L.   Winther Finn  

Acta Oncologica, Vol. 37, Iss. 2, 1998-05 ,pp. : 167-173

Informa Healthcare

Access to resources Recommend Favorite

Sirolimus effects on cancer incidence after kidney transplantation: a meta‐analysis

By  

Cancer Medicine, Vol. 4, Iss. 9, 2015-09 ,pp. : 1448-1459

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comprehensive treatment of advanced primary liver cancer with intraperitoneal chemotherapy or in combination with other therapies: therapeutic observation of 72 cases

By Shen Weifeng  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 2, 2008-02 ,pp. : 69-71

Springer Publishing Company

Access to resources Recommend Favorite